Multiple myeloma : recent progress in diagnosis and treatment
1Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan. chou@niigata-cc.jp
Journal of Clinical and Experimental Hematopathology : JCEH
|December 28, 2012
Summary
Recent advances in multiple myeloma (MM) treatment, including stem-cell transplantation and novel agents, have improved survival rates. Further research into multimodality therapies is crucial for achieving a cure for this challenging hematological malignancy.
Area of Science:
- Hematology
- Oncology
- Clinical Research
Background:
- Multiple myeloma (MM) remains a challenging hematological malignancy.
- Significant progress in understanding MM biology has been made.
- Traditional treatment approaches have limitations in achieving long-term remission.
Purpose of the Study:
- To review recent advancements in multiple myeloma treatment strategies.
- To highlight the impact of novel therapeutic agents on patient outcomes.
- To emphasize the need for continued research in multimodality approaches for MM.
Main Methods:
- Review of recent clinical trials and research publications.
- Analysis of treatment outcomes with high-dose melphalan and autologous stem-cell transplantation.
- Evaluation of the efficacy of immunomodulatory drugs and proteasome inhibitors.
Main Results:
- Novel therapeutic strategies have dramatically altered MM treatment paradigms.
- High response rates and extended overall survival have been achieved.
- Current treatments offer significant improvements but do not guarantee a cure.
Conclusions:
- The combination of high-dose melphalan with autologous stem-cell transplantation has improved MM outcomes.
- Molecular-targeted agents, including immunomodulatory drugs and proteasome inhibitors, are key components of modern MM therapy.
- Further development of multimodality therapeutic approaches is essential to achieve a cure for multiple myeloma.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.